Aurinia Pharmaceuticals

+$0.11 (+0.97%) As of 1:51 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AUPH and other ETFs, options, and stocks.

About AUPH

Aurinia Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of a therapeutic drug to treat autoimmune diseases. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.

CEO
Peter S. Greenleaf
Employees
300
Headquarters
Victoria, British Columbia
Founded
1993

AUPH Key Statistics

Market cap
1.63B
Price-Earnings ratio
—
Dividend yield
—
Average volume
2.03M
High today
$11.51
Low today
$11.30
Open price
$11.34
Volume
47.69K
52 Week high
$33.97
52 Week low
$8.86

AUPH Earnings

-$0.40
-$0.27
-$0.13
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure